Unknown

Dataset Information

Modulating cancer cell survival by targeting intracellular cholesterol transport.


ABSTRACT:

Background

Demand for cholesterol is high in certain cancers making them potentially sensitive to therapeutic strategies targeting cellular cholesterol homoeostasis. A potential approach involves disruption of intracellular cholesterol transport, which occurs in Niemann-Pick disease as a result of acid sphingomyelinase (ASM) deficiency. Hence, a class of lysosomotropic compounds that were identified as functional ASM inhibitors (FIASMAs) might exhibit chemotherapeutic activity by disrupting cancer cell cholesterol homoeostasis.

Methods

Here, the chemotherapeutic utility of ASM inhibition was investigated. The effect of FIASMAs on intracellular cholesterol levels, cholesterol homoeostasis, cellular endocytosis and signalling cascades were investigated. The in vivo efficacy of

SUBMITTER: Kuzu OF 

PROVIDER: S-EPMC5558686 | biostudies-literature | 2017 Aug

REPOSITORIES: biostudies-literature